As the pursue of better patient healthcare continues, medical centers seek novel innovative technologies that can help reduce errors and increase standardization, leading ultimately to best treatment decisions for each patient.
Current patient diagnosis processes fail to identify all biomarkers, most are not tested in the standard of care. This is due to the dependence on adequate tissue to deliver conclusive results, and the costly and cumbersome process involved.
We profile a broad range of biomarkers in real-time, with high sensitivity and specificity, no turnaround time or tissue dependencies.
